First Manhattan’s Solid Biosciences SLDB Stock Holding History

First Manhattan’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-133	Closed	-$1.77K	–	1201
2024 Q1	$1.77K	Hold	133	–	–	﹤0.01%	1292
2023 Q4	$816	Hold	133	–	–	﹤0.01%	1338
2023 Q3	$335	Hold	133	–	–	﹤0.01%	1396
2023 Q2	$696	Hold	133	–	–	﹤0.01%	1353
2023 Q1	$630	Hold	133	–	–	﹤0.01%	1452
2022 Q4	$715	Sell	133 -27	-17%	-$177	﹤0.01%	1598
2022 Q3	$1K	Hold	160	–	–	﹤0.01%	1484
2022 Q2	$1K	Hold	160	–	–	﹤0.01%	1511
2022 Q1	$2K	Buy	160 +27	+20%	+$476	﹤0.01%	1493
2021 Q4	$3K	Hold	133	–	–	﹤0.01%	1456
2021 Q3	$4K	Hold	133	–	–	﹤0.01%	1446
2021 Q2	$7K	Hold	133	–	–	﹤0.01%	1341
2021 Q1	$11K	Hold	133	–	–	﹤0.01%	1223
2020 Q4	$15K	Hold	133	–	–	﹤0.01%	1103
2020 Q3	$4K	Hold	133	–	–	﹤0.01%	1222
2020 Q2	$5K	Hold	133	–	–	﹤0.01%	1249
2020 Q1	$4K	Buy	+133	New	+$6.58K	﹤0.01%	1251
2019 Q4	–	Sell	-133	Closed	-$20K	–	1370
2019 Q3	$20K	Hold	133	–	–	﹤0.01%	1048
2019 Q2	$11K	Hold	133	–	–	﹤0.01%	1171
2019 Q1	$18K	Hold	133	–	–	﹤0.01%	1114
2018 Q4	$53K	Buy	133 +66	+99%	+$31K	﹤0.01%	916
2018 Q3	$47K	Hold	67	–	–	﹤0.01%	989
2018 Q2	$35K	Hold	67	–	–	﹤0.01%	1012
2018 Q1	$7K	Buy	+67	New	+$22.6K	﹤0.01%	1229

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

First Manhattan's SLDB Position: Q2 2024 in Review

First Manhattan sold out of Solid Biosciences (SLDB) in Q2 2024, closing a stake of 133 shares — an estimated $1.77K sold.

First Manhattan first reported a position in SLDB in Q1 2018 and held it in 24 quarters. The position peaked at $53K in Q4 2018. 80 funds tracked by Wall St. Rank hold SLDB as of Q2 2024.

First Manhattan reported no remaining Solid Biosciences position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 133 Solid Biosciences shares in Q2 2024, an estimated $1.77K.
First Manhattan first reported a position in Solid Biosciences in Q1 2018 and held it in 24 quarters.
First Manhattan's Solid Biosciences position peaked at $53K in Q4 2018.
80 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.